Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Mount TAM Biotechnologies, Inc. (OTC: MNTM).

Full DD Report for MNTM

You must become a subscriber to view this report.


Recent News from (OTC: MNTM)

Mount Tam Biotechnologies Announces Appointment of New Member to the Board of Directors
NOVATO, CA, June 28, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce that James Farrell has joined its Board of Di...
Source: GlobeNewswire
Date: June, 28 2018 16:30
Mount Tam Biotechnologies Announces Stockholder Approvals
NOVATO, CA, May 31, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce that stockholders holding a majority of the Co...
Source: GlobeNewswire
Date: May, 31 2018 17:17
Mount Tam Biotechnologies to Present at The MicroCap Conference on October 5th in New York City at the Essex House
NEW YORK, NY / ACCESSWIRE / September 28, 2017 / Mount Tam Biotechnologies (OTC PINK: MNTM) will be presenting at this year's MicroCap Conference on October 5th in New York City. CONFERENCE OVERVIEW AND STRUCTURE The MicroCap Conference is an exclusive event for investors who special...
Source: ACCESSWIRE
Date: September, 28 2017 11:33

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.022N/AN/A0
2018-12-13N/A0.022N/AN/A0
2018-12-120.0250.0220.0260.02270,000
2018-12-110.0250.022750.0250.02282,993
2018-12-100.0210.020.0210.0270,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1230,00070,00042.8571Short
2018-12-1120,00082,99324.0984Cover
2018-12-1020,00070,00028.5714Cover
2018-12-0610,00022,00045.4545Short
2018-12-0420,00020,50097.5610Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MNTM.


About Mount TAM Biotechnologies, Inc. (OTC: MNTM)

Logo for Mount TAM Biotechnologies, Inc. (OTC: MNTM)

Mount Tam Biotechnologies is a specialty biopharmaceutical company formed to develop, optimize and bring to market leading medical compounds to better the health and well being of millions of people who have been affected by autoimmune diseases. The organization s most advanced product, TAM , focuses on the treatment of systemic lupus erythematosus SLE the most common form of lupus.

 

Contact Information

 

 

Current Management

  • Richard Marshak / CEO
  • James P. Stapleton / CFO
  • Timothy Powers / Chief Med. Officer
  • Dr. Brian Kennedy / Chairman
  • Chester Aldridge /
  • Timothy Powers /

Current Share Structure

  • Market Cap: $4,798,863 - 03/09/2018
  • Authorized: 100,000,000 - 03/01/2018
  • Issue and Outstanding: 53,320,702 - 03/01/2018
  • Float: 15,425,625 - 10/21/2015

 


Recent Filings from (OTC: MNTM)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 14 2018
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: April, 20 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 12 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: March, 29 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 07 2017

 

 


Daily Technical Chart for (OTC: MNTM)

Daily Technical Chart for (OTC: MNTM)


Stay tuned for daily updates and more on (OTC: MNTM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MNTM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MNTM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MNTM and does not buy, sell, or trade any shares of MNTM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/